Aligos Therapeutics, Inc.ALGSNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank86
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-3.81
↑ 97% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-131.34
Historical baseline
PeriodValueYoY Change
2025-3.81-100.2%
2024-1.90+59.6%
2023-4.71+55.5%
2022-10.59+88.5%
2021-92.16+57.7%
2020-217.66-39.7%
2019-155.79+72.4%
2018-564.11-